Sectors

BIO
Bio-Rad Laboratories, Inc.
303.79
1 x 303.66
1 x 304.73
bid
ask
+
2.09
0.69%
10:02 AM
timesize
Ytd0.27%
1y23.76%
298.74
day range
303.64
236.73
52 week range
343.12
Open301.00Prev Close301.70Low298.74High303.64Mkt Cap8.16B
Vol15.25KAvg Vol388.28KEPS9.27P/E32.55Forward P/E34.36
Beta1.08Short Ratio3.09Inst. Own94.35%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-3050-d Avg288.73200-d Avg294.931yr Est297.00

BIO News

Assetmark Inc. Raises Stock Holdings in Bio-Rad Laboratories, Inc. $BIO
defenseworld.net
Assetmark Inc. Raises Stock Holdings in Bio-Rad Laboratories, Inc. $BIO

Assetmark Inc. boosted its stake in Bio-Rad Laboratories, Inc. (NYSE: BIO) by 19.0% during the first

Noveris Health Sciences Joins the Biotechnology Innovation Organization (BIO)
thenewswire.com
Noveris Health Sciences Joins the Biotechnology Innovation Organization (BIO)

VANCOUVER, BC, Canada – TheNewswire - July 17, 2026 — Noveris Health Sciences Inc. (CSE: NVRS) (FSE:

BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading Resumes on Wednesday, July 8th
globenewswire.com
BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading Resumes on Wednesday, July 8th

HOLMDEL, N.J., July 07, 2026 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), a glo

Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention
globenewswire.com
Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention

New Taipei City, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C

BIO-key Showcases Passwordless & Biometric Identity Solutions at Jordan Banking Cybersecurity Workshop in Amman on July 6th
globenewswire.com
BIO-key Showcases Passwordless & Biometric Identity Solutions at Jordan Banking Cybersecurity Worksh

BIO-key (BKYI) a global leader in biometric-powered identity & access management to participate at J

Bio-Rad: Activist Involvement Highlights Value-Unlocking Potential
seekingalpha.com
Bio-Rad: Activist Involvement Highlights Value-Unlocking Potential

I assign a "Buy" rating to Bio-Rad Laboratories, citing activist involvement. Elliott's entry signal

Is It Too Late to Buy Bio-Rad Laboratories Inc (BIO) After 6.5% Rally? GF Value Says Undervalued
gurufocus.com
Is It Too Late to Buy Bio-Rad Laboratories Inc (BIO) After 6.5% Rally? GF Value Says Undervalued

On June 25, 2026, Bio-Rad Laboratories Inc (BIO) shares rose 6.5% to $298.29. This movement comes in

HKSTP Leads Largest-Ever Hong Kong Delegation to BIO 2026 Showcasing Life and Health Tech Strength
thenewswire.com
HKSTP Leads Largest-Ever Hong Kong Delegation to BIO 2026 Showcasing Life and Health Tech Strength

41 local tech firms, institutes and university spin-offs head to San Diego to forge global partnersh

BIO CEO says more consistency needed in FDA review process
reuters.com
BIO CEO says more consistency needed in FDA review process

U.S. biotechnology industry trade group BIO worked with the Food and Drug ​Administration on plans a

Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
fool.com
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?

Bio-Rad Laboratories offers high profitability and a liquid balance sheet with a current ratio above

Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention
globenewswire.com
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention

ALAMEDA, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. ( NASDAQ: VANI ) (“Vivani” o

CJ BIO to Showcase TasteNrich® Taste Lab for Sodium Reduction, Clean Label, and Taste Design Solutions at IFT FIRST 2026
prnewswire.com
CJ BIO to Showcase TasteNrich® Taste Lab for Sodium Reduction, Clean Label, and Taste Design Solutio

"Not Just Reducing, But Designing Better Taste" CHICAGO and  DOWNERS GROVE, Ill., June 22, 2026 /PRN

Thermo Fisher Scientific Showcases New Capabilities Across Manufacturing, Clinical Development and AI-Enabled Research at BIO International 2026
businesswire.com
Thermo Fisher Scientific Showcases New Capabilities Across Manufacturing, Clinical Development and A

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will

New Mexico Bioscience Delegation Showcases Innovation and Industry Growth at BIO International Convention 2026
globenewswire.com
New Mexico Bioscience Delegation Showcases Innovation and Industry Growth at BIO International Conve

Albuquerque, NM, June 18, 2026 (GLOBE NEWSWIRE) -- A delegation of economic development, research, h

Daré Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026
globenewswire.com
Daré Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention

President and CEO, Sabrina Martucci Johnson, to participate in featured industry panels and present

Fujifilm Life Sciences at BIO 2026
businesswire.com
Fujifilm Life Sciences at BIO 2026

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millions of patients worldwide still lack access to vital medicin

Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026
globenewswire.com
Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 20

Company to Showcase Integration of AI, Digital Batch Records, and Intelligent Robotics to Accelerate

BIO-key's Fireside Chat at Maxim Group Defense Tech Conf. to Webcast Thur.
globenewswire.com
BIO-key's Fireside Chat at Maxim Group Defense Tech Conf. to Webcast Thur.

Biometric authentication provider BIO-key's (BKYI) CEO will participate in a webcast fireside chat a

BioHarvest Sciences to Present at the 2026 BIO International Convention
newsfilecorp.com
BioHarvest Sciences to Present at the 2026 BIO International Convention

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 18, 2026) - BioHarvest Scien

Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
globenewswire.com
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Co

Company to Conduct Partnering Meetings Focused on Oncology, Liver Disease and Inflammatory Disease R

Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories
benzinga.com
Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories

Elliott Management builds a stake in Bio-Rad (NYSE: BIO) to push for better performance, but family

Nasdaq 100 Drops Over 1%, Oil Tops $106 On Iran Impasse: Stock Market Today
benzinga.com
Nasdaq 100 Drops Over 1%, Oil Tops $106 On Iran Impasse: Stock Market Today

Nasdaq sinks 1.1% as AMAT, MU, ORCL and Vertiv crater on AI capex jitters, while WTI tops $106 and t

Toyo Posts Upbeat Q1 Earnings, Joins Brady, Dominion Energy And Other Big Stocks Moving Higher On Monday
benzinga.com
Toyo Posts Upbeat Q1 Earnings, Joins Brady, Dominion Energy And Other Big Stocks Moving Higher On Mo

TOYO shares rose 13.7% after beating earnings expectations. Other top gainers include JLHL, RAMP, HI

benzinga.com
'Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad' - WSJ

https://www.wsj.com/business/deals/activist-elliott-builds-big-stake-in-life-science-tools-supplier-

benzinga.com
RBC Capital Reinstates Outperform on Bio-Rad Laboratories, Announces $320 Price Target

RBC Capital analyst Dan Leonard reinstates Bio-Rad Laboratories (NYSE:BIO) with a Outperform and

Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU
benzinga.com
Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU

U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on

benzinga.com
Wells Fargo Maintains Equal-Weight on Bio-Rad Laboratories, Lowers Price Target to $290

Wells Fargo analyst Brandon Couillard maintains Bio-Rad Laboratories (NYSE:BIO) with a Equal-Weig

benzinga.com
Bio-Rad Laboratories Lowers FY2026 Sales Guidance from $2.596B-$2.622B to $2.506B-$2.596B vs $2.630B

Bio-Rad Laboratories (NYSE:BIO) lowers FY2026 sales outlook from $2.596 billion-$2.622 billion to $2

Transcript: Bio-Rad Laboratories Q1 2026 Earnings Conference Call
benzinga.com
Transcript: Bio-Rad Laboratories Q1 2026 Earnings Conference Call

benzinga.com
Bio-Rad Laboratories Q1 Adj. EPS $1.89 Misses $1.98 Estimate, Sales $592.100M Beat $588.875M Estimat

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $1.89 per share which missed the anal

Earnings Scheduled For April 30, 2026
benzinga.com
Earnings Scheduled For April 30, 2026

benzinga.com
Citigroup Downgrades Bio-Rad Laboratories to Neutral, Lowers Price Target to $300

Citigroup analyst Patrick Donnelly downgrades Bio-Rad Laboratories (NYSE:BIO) from Buy to Neutral

Pinterest Posts Downbeat Results, Joins DraftKings, Toast, Expedia And Other Big Stocks Moving Lower In Friday's Pre-Market Session
benzinga.com
Pinterest Posts Downbeat Results, Joins DraftKings, Toast, Expedia And Other Big Stocks Moving Lower

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
Bio-Rad Laboratories Sees FY2026 Sales $2.596B-$2.622B vs $2.630B Est

Full-Year 2026 Financial OutlookBio-Rad is providing its financial outlook for the full-year 2026. T

Earnings Summary: Bio-Rad Laboratories Q4
benzinga.com
Earnings Summary: Bio-Rad Laboratories Q4

benzinga.com
Bio-Rad Laboratories Q4 Adj. EPS $2.51 Misses $2.70 Estimate, Sales $693.200M Beat $688.758M Estimat

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.51 per share which missed the anal

Earnings Scheduled For February 12, 2026
benzinga.com
Earnings Scheduled For February 12, 2026

Qiagen Explores Possible Sale After New Buyer Talks: Report
benzinga.com
Qiagen Explores Possible Sale After New Buyer Talks: Report

Qiagen is reviewing strategic options, including a potential sale, after renewed takeover interest f

Earnings Scheduled For October 29, 2025
benzinga.com
Earnings Scheduled For October 29, 2025

benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com
Earnings Scheduled For July 31, 2025

benzinga.com
Earnings Scheduled For May 1, 2025

benzinga.com
Earnings Scheduled For February 13, 2025

benzinga.com
Earnings Scheduled For August 3, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 1076 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

    Tuesday's session saw 729 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Highs On Monday

    Before 10 a.m. ET on Monday, 71 companies hit new 52-week highs.

benzinga.com
Earnings Scheduled For October 29, 2020

  Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings

benzinga.com
Earnings Scheduled For July 30, 2020

Companies Reporting Before The Bell • Mastercard Inc. (NYSE:MA) is expected to report quarterly ear